Kayon Partners

TerraLIX is a manufacturer specializing in hydrogen fuel cell products. The company focuses on developing fuel cells and cell packs designed to operate effectively in extreme environments, ensuring a reliable source of energy even under challenging conditions. By leveraging advanced technology, TerraLIX aims to provide innovative solutions for various applications that require efficient and resilient energy sources.

Mom-sitter is a childcare platform based in Seoul, Korea, that connects parents with caregivers for children aged 0 to 13 years. The platform allows parents to find babysitters by providing detailed information about caregivers, including their specialties and legal backgrounds. This service aims to assure parents of the trustworthiness and qualifications of the caregivers, facilitating ideal matches between families and babysitting professionals. By focusing on the specific needs of both parties, Mom-sitter enhances the childcare experience for parents seeking reliable and skilled babysitting services.

InkHunter, Inc. is a company that specializes in augmented reality technology for tattoo design. Founded in 2014 and based in New York, it has developed a mobile application that allows tattoo artists and enthusiasts to visualize tattoo designs in real-time on any part of the body. Users can select artwork from a gallery or upload their own designs, enabling them to try on tattoos virtually before making a permanent decision. The application utilizes the device's camera to project the chosen design, allowing for adjustments in size and position at various angles until the user is satisfied with the appearance. This innovative approach helps individuals make informed choices about their tattoos.

Intarcia Therapeutics, Inc. is a biopharmaceutical company focused on developing therapies for chronic conditions requiring long-term treatment. The company is known for its innovative drug delivery platform, DUROS, which stabilizes and administers therapeutic proteins and peptides effectively. Among its key products is ITCA 650, currently in phase 3 clinical trials for type 2 diabetes, designed to provide patients with continuous dosing of an incretin mimetic therapy. Intarcia also explores treatments for obesity and other chronic disorders. Established in 1995 and headquartered in Boston, Massachusetts, Intarcia operates a manufacturing facility in Hayward, California, and a research and development center in Durham, North Carolina. The company was previously known as BioMedicines, Inc. before adopting its current name in 2004.

Harrington Re Ltd. is a Bermuda-based multi-line reinsurance company that provides a diverse array of reinsurance services across various property and casualty lines globally. Jointly sponsored by AXIS Capital Holdings Limited and Blackstone Group L.P., the company is registered as a Class 4 Insurer with the Bermuda Monetary Authority. Harrington Re combines its multi-line reinsurance portfolio with a diversified array of alternative investments, offering specialty reinsurance capacity that contributes to the generation of risk-adjusted equity returns for its shareholders. With total capital of approximately $600 million, including $50 million in senior debt, the company has received an A- (“Excellent”) financial strength rating from A.M. Best.

Lateral Investment Management is a California-based private equity firm that provides private credit and growth capital to owner-operated and family-owned middle-market companies in the United States. The firm does not invest in startups and focuses on non-dilutive financing, including bridge and acquisition financing, growth capital, structured finance, and special situations such as financial restructurings for healthy businesses with stressed capital structures. It targets sectors such as manufacturing, healthcare, infrastructure, and technology, and typically pursues North American opportunities with revenues roughly $10 million to $300 million. Investment sizes range from about $10 million to $50 million in growth capital, with up to $75 million in customized structured solutions, often as debt or minority equity without taking control. The intended horizon is a minority-led exit in roughly 1.5 to 3 years. The firm is headquartered in San Mateo, California, with an additional office in New York.

Symbiont.io, Inc. is a financial technology company that specializes in developing a smart contracts platform tailored for institutional applications of blockchain technology. Founded in 2013 and headquartered in New York City, with an additional office in Amsterdam, the company provides a comprehensive infrastructure for capital markets. This includes a unified ledger for sharing business logic and market data, as well as the Symbiont Assembly platform, which facilitates the issuance, tracking, and management of financial instruments such as loans, securities, and commodities. By enabling complex financial instruments to exist within a decentralized blockchain network, Symbiont aims to enhance transparency, reduce risk, and lower costs for financial institutions and government entities. The company has established partnerships with industry leaders, including Vanguard and the State of Delaware, to drive innovation and improve operational efficiency in the capital markets sector.

Founded in 2011, Fundation empowers small businesses by connecting them with financial institutions for working capital and growth financing. It offers outsourced lending programs, point-of-sale financing solutions, and digital credit lending platforms.